ADHD-like behaviors in adolescent mice prenatally exposed to levetiracetam: No safe gestational dose across sexes

Administering medication during pregnancy is always a challenging task. Levetiracetam (LEV), a second-generation antiepileptic drug, has been recognized as relatively safe based on studies assessing neurodevelopmental outcomes of children exposed to it in utero, despite some animal research reporting skeletal abnormalities. The potential link between intrauterine exposure to subtherapeutic or therapeutic doses of LEV and behavioral abnormalities in adolescent offspring has not yet been examined….

via https://pubmed.ncbi.nlm.nih.gov/40858228/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20250902011010&v=2.18.0.post9+e462414